Search alternatives:
largest decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
largest decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
-
621
Fig 29 in each curve fitting results.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
622
Fig 9(b) in the straight-line fitting results.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
623
Specimen packaging process.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
624
Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
625
The relationship between Δσ<sub>n</sub> and τ<sub>1</sub>, <i>JRC</i>.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
626
Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
627
-
628
-
629
-
630
Flowchart of the screening process.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
631
Result of the AMSTAR-2 assessments.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
632
Characteristics of included reviews.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
633
Result of the PRISMA assessments.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
634
Result of the ROBIS assessments.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
635
-
636
-
637
-
638
-
639
-
640